Ally, R., Schurmann, D., Kreisel, W., Carosi, G., Aguirrebengoa, K., Dupont, B., et al. (2001) A Randomized, Double-Blind, Double-Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 33, 1447-1454.

has been cited by the following article:

• TITLE: Candidiasis Treatment Should Pay Attention to the Immune Changing Patients

  AUTHORS: Xiaoyang Yang, Mengjie Wan, Fangping Chen

  KEYWORDS: Candidiasis, Infectious Diseases Society of America, Esophageal Candidiasis

  JOURNAL NAME: Open Journal of Internal Medicine, Vol.6 No.2, May 27, 2016

  ABSTRACT: The guideline of the Infectious Diseases Society of America (IDSA) about candidiasis is a key standard for clinical doctors to treat patients, and textbook to teach medical students. However, in the progress of clinical treatment and documents checking, the immune changing patients, who suffered candidiasis, may be mismatched to the clinical treatment guidelines. The opinion could be shown by the literature of gastrointestinal system, and respiratory system, which suffered severely fungal infection mostly, mainly connected with the outside world and inside organ systems of the human body. They could show some patients have been excess treatment, and we should pay attention to the immune changing patients.